Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...

INDIANAPOLIS — Roche, a Swiss biotechnology company whose U.S. headquarters is in Indianapolis, has announced its intention ...

"The plant will be constructed around 47 acres of land of the closed Khulna Newsprint Mill estimated cost of Taka 3,382 crore ...

President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...

As per Vantage Market Research, the Pharmaceutical Manufacturing Market is poised for growth due to various factors, such as ...

Roche is committing $50 billion while Regeneron inked a $3 billion manufacturing deal with Fujifilm, allowing the pharma to “nearly double” its U.S. large-scale manufacturing capacity.

Following the firm’s $1.75bn acquisition of radiopharmaceuticals company Mariana Oncology and the $745m deal with Ratio ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s tariffs on imports.

major pharmaceutical companies making … U.S. expansions; and policy incentives with the Inflation Reduction Act and CHIPS and Science Act, which include provisions for advanced manufacturing ...

To get it in your inbox, subscribe here. Inside an Indian pharmaceutical manufacturing plant. When they do, one of the biggest losers would likely be generic drug manufacturers. Since they account ...

New Delhi, Apr 16 (PTI) The US health regulator has pulled up Aspen Biopharma Labs for various manufacturing lapses at its Telangana-based active pharmaceutical ingredients production facility.